Indexado en

Licencia y uso

Citaciones

Cited 6 times in

Cited 1 times in

Altmetrics

Grant support

The Paris PVT meeting was supported by FILFOIE, ERN-RARE Liver, Societe Nationale Francaise de Gastroenterologie, and Association Francaise pour l'etude du Foie. This Review was written on behalf of the ERN RARE-LIVER group, and was a study supported by VALDIG, an EASL consortium. .

Análisis de autorías institucional

Compartir

Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies

Publicado en:Lancet Gastroenterology & Hepatology. 9 (9): 859-883 - 2024-09-01 9(9), DOI: 10.1016/S2468-1253(24)00155-9

Autores: Elkrief, Laure; Hernandez-Gea, Virginia; Senzolo, Marco; Albillos, Agustin; Baiges, Anna; Berzigotti, Annalisa; Bureau, Christophe; Murad, Sarwa Darwish; De Gottardi, Andrea; Durand, Francois; Garcia-Pagan, Juan-Carlos; Lisman, Ton; Mandorfer, Mattias; Mclin, Valerie; Moga, Lucile; Nery, Filipe; Northup, Patrick; Nuzzo, Alexandre; Paradis, Valerie; Patch, David; Payance, Audrey; Plaforet, Vincent; Plessier, Aurelie; Poisson, Johanne; Roberts, Lara; Salem, Riad; Sarin, Shiv; Shukla, Akash; Toso, Christian; Tripathi, Dhiraj; Valla, Dominique; Ronot, Maxime; Rautou, Pierre-Emmanuel

Afiliaciones

Resumen

Portal vein thrombosis (PVT) refers to the development of a non-malignant obstruction of the portal vein, its branches, its radicles, or a combination. This Review first provides a comprehensive overview of all aspects of PVT, namely the specifics of the portal venous system, the risk factors for PVT, the pathophysiology of portal hypertension in PVT, the interest in non-invasive tests, as well as therapeutic approaches including the effect of treating risk factors for PVT or cause of cirrhosis, anticoagulation, portal vein recanalisation by interventional radiology, and prevention and management of variceal bleeding in patients with PVT. Specific issues are also addressed including portal cholangiopathy, mesenteric ischaemia and intestinal necrosis, quality of life, fertility, contraception and pregnancy, and PVT in children. This Review will then present endpoints for future clinical studies in PVT, both in patients with and without cirrhosis, agreed by a large panel of experts through a Delphi consensus process. These endpoints include classification of portal vein thrombus extension, classification of PVT evolution, timing of assessment of PVT, and global endpoints for studies on PVT including clinical outcomes. These endpoints will help homogenise studies on PVT and thus facilitate reporting, comparison between studies, and validation of future studies and trials on PVT.

Palabras clave